Novo Nordisk Beijing

Novo Nordisk

Novo Nordisk leaps on new obesity drug data | p...

Novo Nordisk to test anti-obesity molecule in t...

Novo Nordisk hits all-time high as oral obesity...

Signal: Novo Nordisk market cap higher than Dan...

Novo Nordisk receives FDA approval for Wegovy™

Is Novo Nordisk Stock a Buy After its Collapse?...

Novo Nordisk Research Centre opens in Oxford | ...

Novo Nordisk’s Global Commitment to Diabetes Ca...

Novo Nordisk submits diabetes pill for US approval

Novo Nordisk

First: Novo Nordisk India launches oral Semaglu...

Novo Nordisk A/S Sees Unusually Large Options V...

Novo Nordisk - la compañia que trata la diabete...

China OKs Novo Nordisk's Type-2 diabetes treatm...

Novartis' Sandoz dips on debut after lower than...

Novo Nordisk Logo Png

NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...

Novo Nordisk's results are stunning - and it co...

FID prosigue su larga colaboración con Novo Nor...

Novo Nordisk Logo Png

Novo Nordisk amplía sus fármacos contra la obes...

Novo Nordisk experience big profit rise due to ...

Novo Nordisk Posts Record Growth as Demand For ...

Novo Nordisk launches once-a-week diabetes drug...